| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |